GeneDx Holdings
WGS
68.53
-2.99
-4.18%
GeneDx Holdings
US · WGS
#2702 by market cap
Listed 1970
68.53
-2.99
-4.18%
Live - 5344 symbols - heartbeat 209s ago
· 2026-10-08 08:30
Pre-market
68.00
-0.77%
After-hours
68.53
0.00%
Overnight
68.50
-0.04%
- Market cap
- 2.04B
- P/E (TTM)i
- -18.93
- P/Bi
- 8.37
- EPSi
- -0.73
- Div yieldi
- 0.00%
- 52W posi
- 26%
Reader sentiment
Are you bullish or bearish on WGS?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
Piper Sandler Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $130Market Newswire · 2026/4/21
-
Rating change
Wells Fargo Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $155Market Newswire · 2026/2/25
-
Rating change
Piper Sandler Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $63Market Newswire · 2026/6/23
-
Rating change
A Quick Look at Today's Ratings for GeneDx Holdings(WGS.US), With a Forecast Between $130 to $170Market Newswire · 2026/2/24
-
Rating change
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Announces Target Price $85Market Newswire · 2026/5/5
-
Rating change
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Announces Target Price $153Market Newswire · 2026/3/12
-
Wells Fargo Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $75Market Newswire · 2026/7/30
-
Rating change
Jefferies Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $100Market Newswire · 2026/5/27
-
Rating change
Guggenheim Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $100Market Newswire · 2026/3/30
-
Rating change
CCORF Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $100Market Newswire · 2026/4/20
-
Rating change
CCORF Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $170Market Newswire · 2026/3/13
-
A Quick Look at Today's Ratings for GeneDx Holdings(WGS.US), With a Forecast Between $75 to $103Market Newswire · 2026/8/5
-
Rating change
TD Cowen Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $85Market Newswire · 2026/7/16
-
Rating change
A Quick Look at Today's Ratings for GeneDx Holdings(WGS.US), With a Forecast Between $70 to $130Market Newswire · 2026/5/5
-
BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $90Market Newswire · 2026/7/23
-
Rating change
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy RatingMarket Newswire · 2026/6/10
-
Rating change
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $85Market Newswire · 2026/5/14
-
Rating change
Guggenheim Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $74Market Newswire · 2026/6/29
-
Guggenheim Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $83Market Newswire · 2026/10/1
-
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $103Market Newswire · 2026/9/23
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 08:30:23 · For reference only, not investment advice and not tailored to your situation.